MTOR antibody (AA 1521-1620)
Quick Overview for MTOR antibody (AA 1521-1620) (ABIN560948)
Target
See all MTOR (mTOR) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1521-1620
-
Purpose
- Mouse polyclonal antibody raised against a partial recombinant FRAP1.
-
Sequence
- WGLGQWDSME EYTCMIPRDT HDGAFYRAVL ALHQDLFSLA QQCIDKARDL LDAELTAMAG ESYSRAYGAM VSCHMLSELE EVIQYKLVPE RREIIRQIWW
-
Cross-Reactivity
- Human
-
Characteristics
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- MTOR (NP_004949, 1521 a.a. ~ 1620 a.a) partial recombinant protein with GST tag.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handling Advice
- Aliquot to avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
- MTOR (mTOR) (Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR))
-
Alternative Name
- MTOR
-
Background
-
Full Gene Name: mechanistic target of rapamycin
Synonyms: FRAP,FRAP1,FRAP2,RAFT1,RAPT1 -
Gene ID
- 2475
-
NCBI Accession
- NM_004958
-
Pathways
- PI3K-Akt Signaling, RTK Signaling, AMPK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Actin Filament Polymerization, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagy, CXCR4-mediated Signaling Events, BCR Signaling, Warburg Effect
Target
-